Parameters | Numbers (total = 152) |
Age (years) | Mean (SD) 55.64 (9.81) Median (IQR) 55 (13.00) |
Histology Endometrioid adenocarcinoma | 152 |
Pathological stage IA IB IC IIA IIB IIIA IIIB IIIC |
1 (0.7%) 9 (5.9%) 33 (21.7%) 9 (5.9%) 25 (16.4%) 27 (17.8%) 2 (1.3%) 46 (30.3%) |
Grade Well-differentiated Moderately differentiated Poorly differentiated Others |
46 (30.3%) 59 (38.8%) 37 (24.3%) 10 (6.6%) |
WPRT 50 Gy/25 Fractions Others |
134 (88.2%) 18 (11.8%) |
Brachytherapy No boost 2 × 6 Gy 4 ×6 Gy 1 ×7 Gy Others |
53 (34.9%) 57 (37.5%) 11 (7.2%) 17 (11.2%) 14 (9.2%) |
Total treatment time (days) | Mean (SD) 45.59 (12.78) Median (IQR) 42 (12.00) |